Trading update for the year ended 30 June 2025 | 21-Jul-2025 | 07:00 | RNS |
PDMR Dealings | 11-Jul-2025 | 07:00 | RNS |
Interim Results for six months ended 31 Dec 2024 | 31-Mar-2025 | 07:00 | RNS |
Advancement to final phase of PROTECT trial | 27-Mar-2025 | 07:00 | RNS |
New Executive Long Term Incentive Awards | 03-Mar-2025 | 07:00 | RNS |
Grass MATA MPL Phase III data published in Allergy | 17-Feb-2025 | 07:00 | RNS |
Grant of Options | 14-Feb-2025 | 07:00 | RNS |
Half Year Trading update | 28-Jan-2025 | 07:00 | RNS |
PDMR Dealing and Total Voting Rights | 22-Jan-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 15-Jan-2025 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 19-Dec-2024 | 13:41 | RNS |
Block Listing Interim Review | 17-Dec-2024 | 16:19 | RNS |
Result of Annual General Meeting | 16-Dec-2024 | 15:33 | RNS |
Positive Interim Data from PROTECT Trial | 04-Dec-2024 | 07:00 | RNS |
First Patient Dosed in G308 Paediatric Trial | 27-Nov-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 7.85p |
Change Today | -0.15p |
% Change | -1.88 % |
52 Week High | 8.75p |
52 Week Low | 3.88p |
Volume | 135,995 |
Shares Issued | 4,766.44m |
Market Cap | £374.17m |
RiskGrade | 268 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 12,905 @ 7.85p |
16:35 | 6,411 @ 7.85p |
16:35 | 6,494 @ 7.85p |
15:56 | 8,024 @ 7.88p |
11:43 | 20,000 @ 8.18p |
You are here: research